Jaguar Health Inc JAGX

Healthcare

Jaguar Health, Inc. is a commercial-stage pharmaceuticals company. The Company is focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress. It operates through two segments: human health and animal health. The animal health segment is focused on developing and commercializing prescription and non-prescription products for companion and production animals. The human health segment is focused on developing and commercializing of human products and the ongoing commercialization of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with human immunodeficiency virus (HIV)/ acquired immunodeficiency syndrome (AIDS) on antiretroviral therapy. The Canalevia-CA1 is for the treatment of chemotherapy-induced diarrhea (CID) in dogs. Its subsidiary Napo Pharmaceuticals, Inc. focuses on developing and commercializing human prescription pharmaceuticals.

NDAQ:JAGX - Post by User

Jaguar Health Inc

Bullboard Posts

Next >>

Post by Liked2Thinkon Jul 11, 2020 11:30pm

346 Views

Post# 31256734

well

that was a whole bunch of posts from one person

haha

must have been in the vino like I am now.

All I know is that this thing touched 70 cents the other day.

Im not selling a single gold stock until Q3 thats all I know.

right before the election though I see myself selling every stock I own though. who knows what is gonna happen.

Bullboard Posts

Next >>

Hempalta acquires controlling interest in Hemp Carbon Standard